Label: DOCUZEN- sennosides 8.6mg and docusate sodium 50mg tablet

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated November 1, 2023

If you are a consumer or patient please visit this version.

View All Sections
  • Active Ingredients (in each tablet)

    Sennosides from Senna Concentrate 8.6mg

    Docusate Sodium 50mg

  • Purpose

    Laxative

    Stool Softner

  • Uses

    •
    relieves occasional constipation (irregularity)
    •
    generally produces a bowel movement in 6-12 hours
  • Warnings

    Do not use

    •
    laxative products for longer than 1 week unless directed by a doctor
    •
    if you are taking mineral oils, unlesss directed by a doctor

    Ask a doctor before use if you have

    •
    stomach pain
    •
    nausea
    •
    vomiting
    •
    noticed a sudden change in bowel habits that continues over a period of 2 weeks

    Stop use and ask a doctor if

    •
    you have rectal bleeding 
    •
    you fail to have a bowel movement after the use of a laxative.

    These may indicate a serious condition.

    If pregnant or breast feeding,

    ask a healthcare professional before use. 

    Keep out of reach of children.

    In case of overdose, get medical help or contact a Poison Control Center immediately.

  • Directions

    •
    take preferably at bedtime or as directed by a doctor

    age

    starting dosage

    maximum dosage

    Adults and children 12 years and over

    2 tablets once a day 

    4 tablets twice a day

    Children 6 to under 12 years

    1 tablet once a day

    2 tablets  twice a day

    Children 2 to under 6 years 

    1/2 tablet  once a day

    1 tablet twice a day

    Children under 2 years

    ask a doctor

    ask a  doctor
  • Other information

    •
    each tablet contains 10 mg of calcium, sodium 5 mg
    •
    store at 25°C (77°F); excursions permitted between 15o-30oC (59o-86oF)
  • Inactive ingredients

    croscarmellose Sodium, D&C Yellow# 10, dicalcium phosphate, FD&C Yellow #6, magnesium stearate, microcrystalline cellulose, polyvinyl alcohol, polyethylene glycol, sodium benzoate, talc & titanium dioxide.

  • Questions or comments?

    1-800-828-0464 Mon-Fri 8 AM to 4 PM

  • PRINCIPAL DISPLAY PANEL

    VillagePharma

    NDC 71574-700-60

    DOCUZEN

    Sennosides 8.6mg &

    Docusate Sodium 50mg

    60 TABLETS

    Manufactured in the USA

    image of Label
  • INGREDIENTS AND APPEARANCE
    DOCUZEN 
    sennosides 8.6mg and docusate sodium 50mg tablet
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:71574-700
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    SENNOSIDES (UNII: 3FYP5M0IJX) (SENNOSIDES - UNII:3FYP5M0IJX) SENNOSIDES8.6 mg
    DOCUSATE SODIUM (UNII: F05Q2T2JA0) (DOCUSATE - UNII:M7P27195AG) DOCUSATE SODIUM50 mg
    Inactive Ingredients
    Ingredient NameStrength
    CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
    D&C YELLOW NO. 10 (UNII: 35SW5USQ3G)  
    DIBASIC CALCIUM PHOSPHATE DIHYDRATE (UNII: O7TSZ97GEP)  
    FD&C YELLOW NO. 6 (UNII: H77VEI93A8)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
    POLYVINYL ALCOHOL, UNSPECIFIED (UNII: 532B59J990)  
    POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  
    SODIUM BENZOATE (UNII: OJ245FE5EU)  
    TALC (UNII: 7SEV7J4R1U)  
    TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
    Product Characteristics
    Colororange (ORANGE COLOR) Scoreno score
    ShapeROUND (ROUND TABLET) Size10mm
    FlavorImprint Code PH32
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:71574-700-6060 in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product11/27/2018
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM00711/27/2018
    Labeler - Village Pharma (080749749)
    Registrant - Village Pharma (080749749)
    Establishment
    NameAddressID/FEIBusiness Operations
    Pharbest Pharmaceuticals, Inc.557054835MANUFACTURE(71574-700) , PACK(71574-700) , ANALYSIS(71574-700)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!